A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.
about
H pylori antibiotic resistance: prevalence, importance, and advances in testingAntibiotic treatment for Helicobacter pylori: Is the end coming?High-resolution structure of the antibiotic resistance protein NimA fromDeinococcus radioduransQuadruple therapy for symptomatic spontaneous duodenal ulcer diseaseStructural basis of 5-nitroimidazole antibiotic resistance: the crystal structure of NimA from Deinococcus radiodurans.Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis'Rescue' therapies for the management of Helicobacter pylori infection.First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004.Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy.Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates.Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.Age-dependent eradication of Helicobacter pylori in Japanese patients.Structural basis for shikimate-binding specificity of Helicobacter pylori shikimate kinase.Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance.Effect of licorice versus bismuth on eradication of Helicobacter pylori in patients with peptic ulcer disease.Retreatment of Helicobacter pylori infection after initial treatment failure.Second-line rescue therapy of helicobacter pylori infection.Helicobacter pylori: strategies for treatment.Treatment of Helicobacter pylori infection: Past, present and futureMolecular testing for antibiotic resistance in Helicobacter pylori.Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.Update on the management of Helicobacter pylori infection, including drug-resistant organisms.Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.Review article: the treatment of refractory Helicobacter pylori infection.Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.Helicobacter pylori detection and antimicrobial susceptibility testing.Role of NADPH-insensitive nitroreductase gene to metronidazole resistance of Helicobacter pylori strains.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradicationHybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors.
P2860
Q24685864-433CAE17-044B-4C41-AA85-DA08D75940A2Q26777623-73377A0C-9036-4B48-86B7-5CE519AB01B1Q27650779-E049D516-17E1-4A9C-9861-28681145E89AQ28367747-626D3F6F-B332-42E3-A0A5-E5CB269D678CQ30160822-2A08BF5A-F0C9-47FA-AE6F-2BB3D4659038Q33185503-E7DABB37-7E89-4946-807D-FB12A02268C9Q33287535-33F8F7F6-F99B-4DFD-89EB-8E33E8094942Q33371187-AB3B866E-6621-4008-B258-12769581690FQ33869371-D65B26D9-AF1E-4E4A-82BE-E18FD47B643AQ33893567-9FB22D47-FC84-4E0C-8C6B-3EA23A8DF102Q33980234-C1141B42-51DB-4889-81AD-1A95EBF9A166Q33982967-7878A13A-F849-4DB1-A976-D51D91AE9F37Q33994162-CB01B08F-02A9-4DF8-A93F-2D18F06968E9Q34049805-ABF31749-950D-4C37-B6B7-7EC3851B679AQ34102007-7B3C379A-8B03-4643-A169-2C5B3E451165Q34150938-9BA9EE1D-F450-4B0B-AFAF-F3EDE1A5A9EAQ34175742-DCC529BB-9F74-49E7-8D3C-7EFF34603980Q34177260-4F3C5A0A-DAEB-4DC6-875D-5D9EF3727CC6Q34201419-F527F124-2340-4CE1-95BB-A3C21EC5FA4DQ34262531-E5DFB990-AA77-4483-830F-AFA9DC539418Q34409114-7227C6D9-D284-454B-97B0-5694EB6EEA58Q34481541-D4DFDB83-7849-4220-A6E4-094EF2EECAB1Q34508830-1AF716D0-F437-4550-A7E8-BEBC8819269DQ34526014-853BAC6B-2988-417E-B5FB-396D0C5D5B76Q34570815-7851ED6D-E695-4F01-B001-9E1DD1F90CEBQ34596762-F4244A87-7CE6-49D8-A493-B64EC5481C31Q34619427-F8FC850E-8FA7-4D36-A0AD-1E8965AFF397Q34657352-EB326D5B-736D-4519-9946-5CCA5037C901Q34706721-9D800010-8CF8-4342-ADFD-76FAA5154A5BQ34837506-441FDC0C-BDF6-4E53-BE7A-205BEC3E5EB9Q35009862-4D5C7C6C-7195-43FF-83B7-68DF1CD8A3B8Q35010214-3A0575A5-70FF-45C1-890E-E141D260F23FQ35145092-E69FCC7C-A9A8-4926-A23F-2CFFF11EA7FBQ35534113-28943FD4-E632-4066-BF6D-5195DCB12A92Q35783436-2158E49E-7183-431C-95B0-CE7CD6AC24FAQ35832206-47E5DDF5-FBEA-419D-A2A7-7ABA97DF350CQ35841617-925D136D-9C06-4E7E-9F2F-1292CF208DD6Q35843088-B734959D-341C-4AD7-9114-410BC15D792CQ35868940-3817FD9C-1F7D-49B5-ABC0-02BF80E5978EQ35874693-95416F2C-3C31-4F19-B521-E201B5838608
P2860
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A systematic review of Helicob ...... sistance on eradication rates.
@ast
A systematic review of Helicob ...... sistance on eradication rates.
@en
type
label
A systematic review of Helicob ...... sistance on eradication rates.
@ast
A systematic review of Helicob ...... sistance on eradication rates.
@en
prefLabel
A systematic review of Helicob ...... sistance on eradication rates.
@ast
A systematic review of Helicob ...... sistance on eradication rates.
@en
P2093
P2860
P1476
A systematic review of Helicob ...... sistance on eradication rates.
@en
P2093
de Craen AJ
van de Beek D
P2860
P304
P356
10.1046/J.1365-2036.1999.00555.X
P407
P577
1999-08-01T00:00:00Z